A research group at Uppsala University has demonstrated that a new method for PET imaging of Alzheimer's disease is effective ...

A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an ...

Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...

Boston scientists say a routine blood draw might spot the earliest changes of Alzheimer’s long before the brain lights up on ...

The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is the first blood test aiding Alzheimer's diagnosis by detecting amyloid plaques, offering a less invasive alternative to PET scans. The test ...

At the Yale Positron Emission Tomography (PET) Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in brain PET imaging. Subscribe to ...

VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company ...

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE)-- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that it will be ...

A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...